ARCHIVES

Avastin doubles progression-free survival in metastatic disease.

This article is from The Cancer Letter archive.

Vol. 31 No. 21 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

Oncology ManagementL Tax-Exempt Bonds Issued To Expand UPCI; Sentillion, Dua Partner on Info System

March 5, 1999

Individualized Cancer Vaccines Show 90% Survival at 6 Months

December 27, 2013

Shortfall In Centers Budget Threatens Grants Of Half Of The 17 Competing For Renewal In 1980

October 12, 1979

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

September 6, 2002

Grantees Seek $433.5 Million for construction

November 17, 1978

“Imaginary Treatments,” “Wonderful Cures”

June 6, 1997